Avecho Biotechnology Limited announced that Dr. Paul Gavin and Dr. Roksan Libinaki have been respectively appointed as Chief Executive Officer ("CEO") and Chief Operations Officer ("COO") of the Company, effective 1 May 2020. Following the appointment of the CEO and COO, Dr. Gregory Collier would resume his position as Non-Executive Chairman of the Board, effective 1 May 2020. With the appointment of the CEO and COO, Avecho has now assembled the executive team for the next phase of the Company's development.

Dr. Gavin joined the Company in 2002 and has been the Company's Chief Scientific Officer since 2012 and part of the Company leadership for the last 11 years. Dr. Libinaki joined the Company in 2001 and is currently the General Manager of Animal Health and Production. During her tenure, she has had significant involvement across the operational and scientific aspects of the Company's Human Health business, and has led both the Animal Health business and Manufacturing operations.

Dr. Collier and the Board will provide continuous support to the Executive Team in their new roles and commend the team for their dedication and hard work. The Board believes that Dr. Gavin and Dr. Libinaki will continue to make significant contribution to the Company.